SBI may fund $1B for Sun Pharma's $12B Organon buy

9 Jun 2026via India InfolineSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

SBI may commit $1 billion to fund Sun Pharma’s $12 billion acquisition of Organon. This strategic move bolsters Sun Pharma’s global footprint with $12B deal size and $1B SBI backing. The acquisition could significantly enhance product portfolio and overseas revenue. Regulatory approvals remain pending.

📊 STOCKS: SUNPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition

#Acquisition#Funding#SBI#SunPharma

Stocks mentioned

SUNPHARMASUNPHARMA

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →